Schick Shadel Hospital in Seattle, Washington is the #1 rehab center for recovery from drugs and alcohol. Our unique aversion therapy approach has been proven in clinical studies to be effective for eliminating cravings, which are the root of addiction. There are several addiction programs throughout the U.S. that claim to promote recovery from drugs and alcohol. However, we can actually back up our program’s effectiveness with clinical studies and stories from our patients. If you want to learn more about the validity of Schick Shadel Hospital’s aversion therapy program, then keep reading!
Real Patient Stories About Recovery from Drugs and Alcohol
Schick Shadel Hospital has helped people overcome substance use disorder since 1935. Since then, we have successfully treated over 88,000 patients from all different walks of life.
One example is Greg, who attempted to quit alcohol for several years without success. He realized that addiction was something that he couldn’t handle alone, so he checked into Schick Shadel Hospital. After just 10 days, Greg had reclaimed his life and left behind his cravings for alcohol. Over six years later, Greg is still sober and has become a psychotherapist and substance use counselor to help others find the same peace he found. When they’re a good fit, Greg wholeheartedly refers his patients to Schick Shadel Hospital, the #1 rehab center in the U.S.!
We understand that everyone’s journey through recovery from drugs and alcohol is unique, yet the science behind our aversion therapy treatment is simple and proven to address the root of the addiction. If you would like, you can read more patient stories by clicking HERE.
To learn more about the clinical studies that help reinforce the efficacy of Schick Shadel Hospital’s aversion therapy approach, keep reading!
AN fMRI STUDY ON THE NEUROBIOLOGICAL MECHANISM OF CHEMICAL AVERSION THERAPY
The University of Washington in Seattle, Washington published the most recent scientific study on the effectiveness of aversion therapy in September of 2017. This was the first fMRI study to measure the effects of chemical aversion therapy on alcohol craving-related brain activity. Before treatment, the thirteen participants in the study had all received a DSM-4 diagnosis for alcohol use disorder (AUD) and had reported craving alcohol.
Subjects received a pre-treatment fMRI scan during self-generated alcohol stimulus cues before beginning aversion therapy at Schick Shadel Hospital. Eight days later, after four of the five counterconditioning treatments were complete, each subject received one post-treatment fMRI brain scan. Patients also answered single-item questions about their current level of “wanting, liking, and craving alcohol” before and after treatment.
The results of the study by the University of Washington found that patients reported large and statistically significant pre- to post-treatment reductions for wanting, liking, and craving alcohol. The results from the fMRI brain scans were consistent with the prediction that chemical aversion therapy would reduce cravings. The subjects’ post-treatment fMRI brain scans showed statistically significant reductions in alcohol cue-related brain activity in the occipital cortex.
When contacted one year after treatment, 69% of the subjects in the fMRI study reported still being sober. All participants in this study reported craving alcohol before treatment. However, after treatment, the participants reported avoidance/aversion to alcohol. The results of the study indicate that a major factor in the success of the chemical aversion therapy technique is the targeted craving reduction. This was a primary goal of treatment because craving poses an increased risk of relapse after treatment.1
A FOLLOWUP SURVEY OF 600 PATIENTS THAT WERE TREATED USING AVERSION THERAPY AND NARCOTHERAPY
A study that consisted of a sample of 600 patients who were treated with aversion therapy and narcotherapy at Schick Shadel Hospital was published by the U.S. National Library of Medicine in the summer of 1993. An independent research organization made telephone contact with 427 of the patients between 12 and 20 months after completion of treatment. Of these, 65.1% were totally abstinent for one year after treatment and 60.2% were abstinent until follow-up, which was an average of 14.7 months after treatment.2
Of the alcoholics that received treatment at Schick Shadel Hospital, 52% of them were also using or dependent on other drugs at the time of admission. Of the patients that were treated for cocaine dependence, 49 out of 75 of them were contacted an average of 14.7 months after treatment. The 12-month abstinence for cocaine patients was 83.7% and their “total” abstinence was 81.6%.
Out of the 52% of alcoholics that were also using or dependent on other drugs at the time of admission, 47 of them treated for marijuana dependence. Out of these 47 patients, 30 of them were contacted an average of 14.7 months after treatment. The marijuana 12-month and “total” abstinence rate was 70% for both groups.3
Schick Shadel Hospital is the #1 Rehab Center
Some of the most common programs for recovery from drugs and alcohol could never come close to the same results found in the studies above. For example, the most common recovery program has an actual success rate for long-term recovery of only 5-8%.4 Other rehab programs often use unreliable information to help boost their marketing. However, one thing is clear: Schick Shadel Hospital has been scientifically substantiated by objective, third-party research organizations. Our patients consistently experience clinical benefit because we treat addiction as a psychological response to stimuli rather than a mental or social dysfunction. It’s obvious that Schick Shadel Hospital is the #1 rehab center if you compare the results from our aversion therapy approach to other programs.
Our aversion therapy approach isn’t for everyone. Only if you are serious about recovery from drugs and alcohol, then our program may be right for you. Our program might be right for you if you need the help of a scientifically proven addiction treatment with a clinical focus rather than a social or emotional “reset.”
This blog is part of a series – ‘What You Need to Know About Schick Shadel Hospital’
Check out the rest of the series by clicking the links below:
1 Elkins, R., Richards, T., Nielsen, R., Repass, R., Stahlbrandt, H., & Hoffman, H. (2017). The Neurobiological Mechanism of Chemical Aversion (Emetic) Therapy for Alcohol Use Disorder: An fMRI Study. Frontiers In Behavioral Neuroscience, 11. doi:10.3389/fnbeh.2017.00182
2 PJ, S. (2019). Treatment outcome of 600 chemically dependent patients treated in a multimodal inpatient program including aversion therapy and pentothal interviews. – PubMed – NCBI. Ncbi.nlm.nih.gov. Retrieved 10 September 2019, from https://www.ncbi.nlm.nih.gov/pubmed/8105103
3 Smith, J., & Frawley, P. (1993). Treatment outcome of 600 chemically dependent patients treated in a multimodal inpatient program including aversion therapy and pentothal interviews. Journal Of Substance Abuse Treatment, 10(4), 359-369. doi:10.1016/0740-5472(93)90021-s
4 Glaser, G. (2015). The Bad Science of Alcoholics Anonymous. The Atlantic. Retrieved 30 January 2019, from https://www.theatlantic.com/magazine/archive/2015/04/the-irrationality-of-alcoholics-anonymous/386255/
5 Drug Rehab Success Rates and Statistics. (2019). American Addiction Centers. Retrieved 13 November 2019, from https://americanaddictioncenters.org/rehab-guide/success-rates-and-statistics